Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
暂无分享,去创建一个
R. Blasczyk | B. Maecker-Kolhoff | B. Eiz-Vesper | R. Stripecke | C. Figueiredo | C. Bunse | S. Tischer | S. Immenschuh | S. Borchers | Daria Dieks | Cinja Sukdolak | Sylvia Borchers
[1] J. Altman,et al. MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells , 2003, Current protocols in immunology.
[2] A. Abu-Khader,et al. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation ‐ a comparison of different assays for the detection of cytomegalovirus‐specific T cells , 2013, European journal of haematology.
[3] E. Mischak-Weissinger,et al. CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] S. Exler,et al. The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[5] S. Stevanović,et al. Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. Blasczyk,et al. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes. , 2012, International immunology.
[7] J. Teruya-Feldstein,et al. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. , 2012, Blood.
[8] J. P. Houchins,et al. Combining ELISPOT and ELISA to measure amounts of cytokines secreted by a single cell. , 2012, Methods in molecular biology.
[9] R. Blasczyk,et al. Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequencies , 2011, Journal of Translational Medicine.
[10] A. Ganser,et al. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation , 2011, Transplant infectious disease : an official journal of the Transplantation Society.
[11] D. Busch,et al. Adoptive transfer and selective reconstitution of streptamer‐selected cytomegalovirus‐specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation , 2011, Transfusion.
[12] S. Mackinnon,et al. Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] H. Einsele,et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. , 2010, Blood.
[14] A. Gatti,et al. Search for Anti-EA(D) Antibodies in Subjects with an “Isolated VCA IgG” Pattern , 2010, International journal of microbiology.
[15] J. Stoltz,et al. Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy , 2010, Journal of immunotherapy.
[16] G. Ledderose,et al. Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. , 2010, Blood.
[17] R. Pass,et al. Enzyme-Linked Immunosorbent Assay for Measurement of Cytomegalovirus Glycoprotein B Antibody in Serum , 2010, Clinical and Vaccine Immunology.
[18] Ann M Leen,et al. Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation , 2010, Expert opinion on biological therapy.
[19] H. Heuft,et al. Soluble Recombinant CMVpp65 Spanning Multiple HLA Alleles for Reconstitution of Antiviral CD4+ and CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation , 2010, Journal of immunotherapy.
[20] M. Freund,et al. Multimer technologies for detection and adoptive transfer of antigen-specific T cells , 2010, Cancer Immunology, Immunotherapy.
[21] Z. Berneman,et al. Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays. , 2009, Journal of immunological methods.
[22] C. Rinaldo,et al. Multiple T-Cell Responses to Human Immunodeficiency Virus Type 1 Are Enhanced by Dendritic Cells , 2009, Clinical and Vaccine Immunology.
[23] J. Castillo,et al. Infectious Agents and Cancer Open Access Ebv-positive Diffuse Large B-cell Lymphoma in a Human T-lymphotropic Virus Type 1 Carrier , 2009 .
[24] M. John,et al. Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses. , 2009, Journal of immunological methods.
[25] K. Lucas,et al. Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[26] D. Lilleri,et al. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection , 2008, Haematologica.
[27] H. Einsele,et al. CMV-specific T cell therapy. , 2008, Blood cells, molecules & diseases.
[28] J. Lowenthal,et al. ELISPOT and intracellular cytokine staining: novel assays for quantifying T cell responses in the chicken. , 2008, Developmental and comparative immunology.
[29] H. Heslop,et al. Adoptive cellular immunotherapy for viral diseases , 2008, Bone Marrow Transplantation.
[30] R. Blasczyk,et al. Bioinformatic integration of biomechanics makes HLA sequencing universally applicable. , 2007, Tissue antigens.
[31] F. Marincola,et al. CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects , 2007, Journal of Translational Medicine.
[32] C. Rooney,et al. Adoptive immunotherapy for herpesviruses. , 2007 .
[33] T. Lion,et al. Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation , 2006, British journal of haematology.
[34] A. Rickinson,et al. CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells , 2005, The Journal of experimental medicine.
[35] R. Handgretinger,et al. Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation , 2005, British journal of haematology.
[36] Elizabeth Sinclair,et al. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. , 2003, Journal of immunological methods.
[37] M. Villacres,et al. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles. , 2003, Human immunology.
[38] J. Altman,et al. MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells , 2003, Current protocols in immunology.
[39] M. Hudgens,et al. Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. , 2003, The Journal of infectious diseases.
[40] S. Rowland-Jones,et al. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. , 2002, Blood.
[41] P. Ott,et al. Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetes , 2002, Diabetes/metabolism research and reviews.
[42] D. Busch,et al. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer , 2002, Nature Medicine.
[43] Hans-Georg Rammensee,et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. , 2002, Blood.
[44] E. Thiel,et al. Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells. , 2001, Journal of immunological methods.
[45] J. Wagner,et al. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. , 2000, Blood.
[46] B. Boehm,et al. Direct Visualization of Cytokine-Producing Recall Antigen-Specific CD4 Memory T Cells in Healthy Individuals and HIV Patients1 , 2000, The Journal of Immunology.
[47] T. Whiteside,et al. Evaluation of the Modified ELISPOT Assay for Gamma Interferon Production in Cancer Patients Receiving Antitumor Vaccines , 2000, Clinical Diagnostic Laboratory Immunology.
[48] J A Madrigal,et al. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. , 1999, Journal of immunology.
[49] K. Fujii,et al. Rapid Determination of Epstein-Barr Virus–Specific CD8+T-Cell Frequencies by Flow Cytometry , 1999 .
[50] S. Rowland-Jones,et al. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. , 1999, Journal of immunology.
[51] G. Ogg,et al. Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo , 1998, The Journal of experimental medicine.
[52] X. Jin,et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.
[53] A. Rickinson,et al. Epitope focusing in the primary cytotoxic T cell response to Epstein- Barr virus and its relationship to T cell memory , 1996, The Journal of experimental medicine.
[54] J. Levy,et al. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. , 1991, Clinical and experimental immunology.